19-38731207-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_144691.4(CAPN12):ā€‹c.1974C>Gā€‹(p.Asn658Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000062 ( 0 hom. )

Consequence

CAPN12
NM_144691.4 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.12
Variant links:
Genes affected
CAPN12 (HGNC:13249): (calpain 12) The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes a member of the calpain large subunit family. [provided by RefSeq, Jun 2012]
ACTN4 (HGNC:166): (actinin alpha 4) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes. Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3808489).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CAPN12NM_144691.4 linkuse as main transcriptc.1974C>G p.Asn658Lys missense_variant 19/21 ENST00000328867.9 NP_653292.2 Q6ZSI9
ACTN4NM_004924.6 linkuse as main transcriptc.*1775G>C 3_prime_UTR_variant 21/21 ENST00000252699.7 NP_004915.2 O43707-1A0A0S2Z3G9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CAPN12ENST00000328867.9 linkuse as main transcriptc.1974C>G p.Asn658Lys missense_variant 19/211 NM_144691.4 ENSP00000331636.3 Q6ZSI9
ACTN4ENST00000252699.7 linkuse as main transcriptc.*1775G>C 3_prime_UTR_variant 21/211 NM_004924.6 ENSP00000252699.2 O43707-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1460402
Hom.:
0
Cov.:
34
AF XY:
0.00000413
AC XY:
3
AN XY:
726512
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000809
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 06, 2021The c.1974C>G (p.N658K) alteration is located in exon 19 (coding exon 19) of the CAPN12 gene. This alteration results from a C to G substitution at nucleotide position 1974, causing the asparagine (N) at amino acid position 658 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
.;.;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.79
T;.;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.38
T;T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.1
.;.;M
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-4.3
.;.;D
REVEL
Benign
0.18
Sift
Benign
0.16
.;.;T
Sift4G
Benign
0.097
T;D;T
Polyphen
1.0
.;.;D
Vest4
0.70, 0.73
MutPred
0.44
.;.;Gain of methylation at N658 (P = 0.0124);
MVP
0.49
MPC
0.33
ClinPred
0.98
D
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.38
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-39221847; API